Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too

Br J Haematol. 2006 Sep;134(6):645-6. doi: 10.1111/j.1365-2141.2006.06238.x. Epub 2006 Aug 1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carmustine / therapeutic use
  • Cytarabine / therapeutic use
  • Drug Administration Schedule
  • Etoposide / therapeutic use
  • Hodgkin Disease / drug therapy*
  • Humans
  • Melphalan / therapeutic use
  • Recurrence
  • Salvage Therapy

Substances

  • Cytarabine
  • Etoposide
  • Melphalan
  • Carmustine

Supplementary concepts

  • BEAM regimen